CIK 0001991792
- Large accelerated filer
CG Oncology, Inc.
Sign in to watch- Ticker
- CGON
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 371611499
- Phone
- +1 949-409-3700
- Business address
- 3000 PEGASUS PARK DRIVE, SUITE 1640, DALLAS, TX, 75247
- 4 Open-market buy Chief Medical Officer bought 1,315 shares at $19.00 ($24,985)
- 4 Open-market buy CFO & Secretary bought 2,000 shares at $19.00 ($38,000)
- 4 Open-market buy Director bought 263,157 shares at $19.00 ($4,999,983)
- 4 Open-market buy 10% owner bought 400,000 shares at $19.00 ($7,600,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 5 of 5 · 96 filings